BIO offering history
Every offering-related filing in BIO-RAD LABORATORIES, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,004 filings back to Jun 15, 2011.
| Date | Filing | What it means | |
|---|---|---|---|
| Feb 25, 2022 | 424B2 → | EXECUTED | Prospectus supplement priced — shares or notes (large filers: often a bond deal) |
| Feb 24, 2022 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Feb 23, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 15, 2022 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
BIO offering FAQ
When did BIO last execute an offering?
Per SEC filings, BIO-RAD LABORATORIES, INC.'s most recent priced offering document is a 424B2 filed 2022-02-25. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did BIO last announce or register an offering?
The most recent registration is a S-3ASR filed 2022-02-15. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.